S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ALGS Aligos Therapeutics Inc

26.42

2.68 (11.29%)

01 Feb 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Aligos Therapeutics Charts.

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Aligos Therapeutics Charts.

Aligos Therapeutics Inc News

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Saturday 14 December 2024 (2 months ago) • GlobeNewswire Inc.

Aligos Therapeutics to Present at Investor Conferences in December
Wednesday 27 November 2024 (2 months ago) • GlobeNewswire Inc.

Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
Wednesday 20 November 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
Thursday 7 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024
Thursday 31 October 2024 (3 months ago) • GlobeNewswire Inc.

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184
Tuesday 22 October 2024 (3 months ago) • GlobeNewswire Inc.

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024
Wednesday 16 October 2024 (4 months ago) • GlobeNewswire Inc.

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 11 October 2024 (4 months ago) • GlobeNewswire Inc.

More Aligos Therapeutics Inc News Articles

Australia And New Zealan...

Commonwealth Bank Of Aus...

JP Morgan Chase

S&P ASX 300 Metals and M...

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions